Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc PMEDF


Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Comment by badog222on Nov 23, 2020 3:40pm
126 Views
Post# 31954487

RE:RE:RE:RE:RE:RE:RE:PMED board

RE:RE:RE:RE:RE:RE:RE:PMED boardWell....it's also a common practice for pharma companies to sell to USA customers for much higher prices than in other countries.   Does that make it right.   

These small listed companies can put out news releases for free.  They could buy email lists of potential investors to send info to.  So why would they choose to pay thousands of dollars to have a so-called news outfit put out the same info?   These so-called news outfits (and I use the term news begrudgingly) are available for hire.   They are told the current situation and then they are paid to put out a glowing report to fool the 'uneducated' get rich quick investors....those that would think that a glowing article on some company must indicate that it is worth investing in immediately.   And the company can try to act as if they didn't just engage in a promotion game.  An outside news outfit wrote the story...ya know.  Surely they had no bias.  For new investors 
It's not until their investment is under water by 50% that they realize that they were duped.  

Even the so-called news outfit that writes the glowing story warns in thier disclosure not to take what they printed as investment advice.  In other words....we may not even believe what we just printed.   But they paid us to print it.  

In this case it appears they required cash to print the glowing article.     Why not take shares?   Well....the shares may turn out to be worth zero.   They want cash.  They won't gamble on unproven products or services.   Cash only!

Badog
<< Previous
Bullboard Posts
Next >>